CX Institutional Purchases 15,983 Shares of Colgate-Palmolive Company $CL

Key Points

• CX Institutional boosted its stake in Colgate‑Palmolive (NYSE:CL) by 21% in the 4Q, buying 15,983 shares to hold 92,262 shares valued at about $7.29M, with institutional investors owning roughly 80.41% of the stock.
• Q1 results beat expectations—EPS $0.97 and revenue $5.32B—Colgate also raised its quarterly dividend to $0.53 and expanded a strategic growth and restructuring program aimed at margin recovery.
• Company insiders sold heavily last quarter (totaling 184,683 shares worth about $17.49M, leaving insiders with 0.43% ownership), while analysts rate CL a Moderate Buy with an average price target near $95.56 (12 Buys, 6 Holds).

CX Institutional raised its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 21.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 92,262 shares of the company's stock after buying an additional 15,983 shares during the quarter. CX Institutional's holdings in Colgate-Palmolive were worth $7,291,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CL. Maseco LLP bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $27,000. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $29,000. Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $30,000. Global Wealth Strategies & Associates grew its holdings in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company's stock valued at $32,000 after purchasing an additional 300 shares during the last quarter. Finally, Grove Bank & Trust grew its holdings in shares of Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company's stock valued at $32,000 after purchasing an additional 263 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CL shares. Citigroup lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a report on Monday, February 2nd. Evercore lifted their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an "outperform" rating in a report on Monday, February 2nd. Royal Bank Of Canada set a $102.00 price target on shares of Colgate-Palmolive in a report on Thursday, April 9th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $97.00 to $95.00 and set an "overweight" rating on the stock in a report on Friday, April 17th. Finally, Piper Sandler decreased their price target on shares of Colgate-Palmolive from $96.00 to $92.00 and set an "overweight" rating on the stock in a report on Wednesday, April 8th. Twelve investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $95.56.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 184,683 shares of company stock valued at $17,486,693 in the last quarter. 0.43% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Up 2.1%

NYSE:CL opened at $87.15 on Friday. The firm's 50 day simple moving average is $87.95 and its 200 day simple moving average is $84.11. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a market cap of $69.92 billion, a PE ratio of 33.91, a P/E/G ratio of 4.46 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period last year, the company earned $0.91 EPS. The firm's revenue was up 8.4% compared to the same quarter last year. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.85 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. Colgate-Palmolive's dividend payout ratio is 80.92%.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Q1 top‑ and bottom‑line beat — Colgate reported EPS of $0.97 vs. $0.95 consensus and revenue of $5.32B (up 8.4% YoY), driven by pricing and volume growth; organic sales rose and base business EPS increased. Colgate Q1 Earnings & Sales Beat Estimates on Pricing & Volume Growth
• Positive Sentiment: Strong international demand for core oral and personal care boosted results and topline momentum, a cited driver behind the beat. Colgate‑Palmolive beats Q1 estimates on strong international demand
• Positive Sentiment: Board expands strategic growth & restructuring program — management is accelerating a multi‑year program (approved July 2025) intended to drive growth and cost savings, which supports margin recovery expectations. Colgate‑Palmolive Expands Strategic Growth and Restructuring Program
• Neutral Sentiment: Management commentary and slides — the earnings call and slide deck provide detail on region‑level trends, pricing versus volume dynamics, and the timing of savings from the restructuring program. Review the transcript/slides for forward commentary. Colgate‑Palmolive Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Analysts updated forecasts ahead of and after the print — some revisions were already in place heading into the quarter; keep an eye on any further changes to price targets or model assumptions. Colgate‑Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Negative Sentiment: Margin pressure and one‑time/SGPP charges — GAAP EPS fell YoY (to $0.80) and gross profit margin slipped ~20 bps; management flagged costs and restructuring/SGPP charges that weighed on margins this quarter. These items are a watch point for near‑term profitability until savings materialize. Colgate Announces 1st Quarter 2026 Results

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.